Sophos Central Management of XG Firewall Now Available Through Early Access Program OXFORD, United Kingdom, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Sophos (LSE: SOPH), a global leader in network and endpoint security, today announced that its next-generation Sophos XG Firewall is now...

Hemispherx Updates Status of Immuno-Oncology Program in Pancreatic Cancer PHILADELPHIA, July 10, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced that 12 pancreatic patients are currently undergoing treatment with single-agent Ampligen...

Hemispherx Announces First Shipment of Newly Manufactured Rintatolimod (Ampligen®) for Sale to Early Access Program in Europe PHILADELPHIA, Jan. 26, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) announced today that an order of newly manufactured rintatolimod (Ampligen®) for sale utilizing the Early Access...